|
Invited Speakers:
|
|
Key speaker include * Dr Alain Beck, Head of Physio-Chemistry Department, Centre d’Immunologie Pierre Fabre * Dr Paul Parren, Senior Vice President, Research and Development, GenMab * Dr Nils Lonberg, Senior Vice President and Scientific Director, Medarex * Dr Janice Reichert, Senior Research Fellow, Tufts Center for the Study of Drug Development and Editor-in-Chief, mAbs * Dr Nathalie Corvaïa, Head of Research, Centre d’Immunologie Pierre Fabre * Dr Robert Lutz, Executive Director, ImmunoGen * Dr Tony Maschio, Partner, Life Sciences and European Patent Attorney, Edwards, Angell, Palmer & Dodge LLP * Professor Stefan Dübel, Director, Department of Biotechnology, University of Braunschweig, Germany * Dr Iqbal Grewal, Vice President, Preclinical Therapeutics, Seattle Genetics * Dr Eric Ezan, Head, Pharmacology and Immuanalytics, CEA * Dr Stephen Demarest, Senior Scientist, Department of Protein Chemistry, Biogen Idec * Dr Debbie Law, Chief Scientific Officer, Ablynx
|
|